A recent study has shown that stage II/II CRC patients with high PD-L1 gene expression in their TME, have a poorer relapse free survival following standard 5-FU based adjuvant chemotherapy compared to the untreated setting, while patients with low PD-L1 displayed a significant benefit from adjuvant treatment [98]. Here, CD274 is linked to colorectal carcinoma.